Package Leaflet: Information for the User
Brilique 60 mg film-coated tablets
ticagrelor
Read this leaflet carefully before you start taking this medicine, because it contains important information for you
1. What is Brilique and what is it used for
2. What you need to know before you take Brilique
3. How to take Brilique
4. Possible side effects
5. Storage of Brilique
6. Contents of the pack and other information
What is Brilique
Brilique contains an active ingredient called ticagrelor. It belongs to a group of medications called antiplatelet agents.
What is Brilique used for
Brilique in combination with acetylsalicylic acid (another antiplatelet agent) should only be used in adults. You have been prescribed this medication because you have had:
This medication reduces the risk of having another myocardial infarction, a cerebral infarction, or dying from a heart or blood vessel disease.
How Brilique works
Brilique acts on cells called 'platelets' (also called thrombocytes). These very small blood cells help stop bleeding by grouping together to block small holes in blood vessels that are cut or damaged.
However, platelets can also form clotsinsidedamaged blood vessels in the heart and brain. This can be very dangerous because:
Brilique helps prevent platelet aggregation. This reduces the likelihood of a blood clot forming that can reduce blood flow.
Do not take Brilique if:
Do not take Brilique if you are in any of the above circumstances. If you have doubts, consult your doctor or pharmacist before taking this medication.
Warnings and precautions
Consult your doctor or pharmacist before taking Brilique if:
If any of the above applies to your case (or if you are unsure), consult your doctor or pharmacist before taking this medication.
If you are taking Brilique and heparin:
Children and adolescents
Brilique is not recommended for children and adolescents under 18years.
Use of Brilique with other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.This is because Brilique may affect the mechanism of action of some medications and some medications may affect Brilique.
Inform your doctor or pharmacist if you are taking any of the following medications:
Particularly, inform your doctor or pharmacist if you are taking any of the following medications that increase the risk of hemorrhage:
Also inform your doctor that, due to taking Brilique, you may have a higher risk of bleeding if your doctor administers fibrinolytics, often referred to as 'clot dissolvers', such as streptokinase or alteplase.
Pregnancy and breastfeeding
Brilique is not recommended if you are pregnant or may become pregnant. Women should use appropriate contraceptive methods to avoid pregnancy while taking this medication.
Consult your doctor before taking this medication if you are breastfeeding. Your doctor will explain the benefits and risks of taking Brilique during this period.
If you are pregnant or breastfeeding, or if you think you may be pregnant or plan to become pregnant, consult your doctor or pharmacist before taking this medication.
Driving and operating machinery
Brilique is unlikely to affect your ability to drive and operate machinery. If you feel dizzy or confused while taking this medication, be careful while driving or operating machinery.
Sodium content
This medication contains less than1mmol of sodium (23mg) per dose, which is essentially 'sodium-free'.
Follow exactly the administration instructions of this medication indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
How much to take
Taking Brilique with other medications for blood clotting
Your doctor will also prescribe you acetylsalicylic acid normally. This is a substance present in many medications used to prevent blood clotting. Your doctor will tell you how much to take (usually between 75-150 mg per day).
How to take Brilique
Difficulty swallowing the tablet
If you have difficulty swallowing the tablet, you can crush it and mix it with water as follows:
If you are in the hospital, they may administer this tablet mixed with a little water and through a tube through your nose (nasogastric tube).
Taking more Brilique than you should
If you take more Brilique than you should, consult your doctor or go to the hospital immediately. Bring the medication packaging with you. You may have a higher risk of bleeding.
Missing a dose of Brilique
Stopping treatment with Brilique
You should not stop Brilique without consulting your doctor. Take this medication regularly and for as long as your doctor tells you to. If you stop taking Brilique, you may increase the risk of having another heart attack or a stroke or dying from a heart or blood vessel disease.
If you have any other questions about using this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them. This medicine can cause the following side effects:
Brilique affects blood clotting, so most side effects are related to bleeding. Bleeding can occur anywhere in the body. A certain level of bleeding is common (such as bruises and nosebleeds). Severe bleeding is rare but can be potentially life-threatening.
Inform your doctor immediately if you notice any of the following - you may need urgent medical treatment:
Consult your doctor if you notice any of the following:
Other possible side effects
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Rare (may affect up to 1 in 100 people)
Frequency unknown (cannot be estimated from available data)
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist,even if it is a side effect that does not appear in this leaflet. You can also report them directly through the national reporting system included in theAppendixV. By reporting side effects, you can contribute to providing more information about the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the blister pack and on the outer packaging after EXP/CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medicines should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the packaging and medication that you no longer need. By doing so, you will help protect the environment.
Core of the tablet: mannitol (E421), calcium hydrogen phosphate dihydrate, sodium carboxymethylcellulose type A, hydroxypropylcellulose (E463), magnesium stearate (E470b).
Coating of the film-coated tablets: hypromellose (E464), titanium dioxide (E171), macrogol 400, iron oxide black (E172), iron oxide red (E172).
Appearance of the product and contents of the package
Film-coated tablet (tablet): The tablets are round, biconvex, pink, film-coated, marked with a "60" over a "T" on one side.
Brilique is available in:
Only some pack sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder:
AstraZeneca AB
SE-152 57 Södertälje
Sweden
Responsible manufacturer:
AstraZeneca AB
Gärtunavägen
SE-151 85 Södertälje
Sweden
For further information about this medicinal product, please consult the representative of the marketing authorization holder in your country:
België/Belgique/Belgien AstraZeneca S.A./N.V. Tel: +32 2 370 48 11 | Lietuva UAB AstraZeneca Lietuva Tel: +370 5 2660550 |
Luxembourg/Luxemburg NV AstraZeneca SA Tél/Tel: +32 2 370 48 11 | Lietuva UAB AstraZeneca Lietuva Tel: +370 5 2660550 |
Czech Republic AstraZeneca Czech Republic s.r.o Tel: +420 222 807 111 | Magyarország AstraZeneca kft Tel.: +36 1 883 6500 |
Danmark AstraZeneca A/S Tlf: +45 43 66 64 62 | Malta Associated Drug Co. Ltd Tel: +356 2277 8000 |
Deutschland AstraZeneca GmbH Tel: +49 40 809034100 | Nederland AstraZeneca BV Tel: +31 85 808 9900 |
Eesti AstraZeneca Tel: +372 6549 600 | Norge AstraZeneca AS Tlf: +47 21 00 64 00 |
Ελλάδα AstraZeneca A.E. Τηλ: +30 2 106871500 | Österreich AstraZeneca Österreich GmbH Tel: +43 1 711 31 0 |
España AstraZeneca Farmacéutica Spain, S.A. Tel: +34 91 301 91 00 | Polska AstraZeneca Pharma Poland Sp. z o.o. Tel.: +48 22 245 73 00 |
France AstraZeneca Tél: +33 1 41 29 40 00 | Portugal AstraZeneca Produtos Farmacêuticos, Lda. Tel: +351 21 434 61 00 |
Hrvatska AstraZeneca d.o.o. Tel: +385 1 4628 000 | România AstraZeneca Pharma SRL Tel: +40 21 317 60 41 |
Ireland AstraZeneca Pharmaceuticals (Ireland) DAC Tel: +353 1609 7100 | Slovenija AstraZeneca U K Limited Tel: +386 1 51 35 600 |
Ísland Vistor hf Sími: +354 535 7000 | Slovenská republika AstraZeneca AB o.z. Tel: +421 2 5737 7777 |
Italia AstraZeneca S.p.A. Tel: +39 02 00704500 | Suomi/Finland AstraZeneca Oy Puh/Tel: +358 10 23 010 |
Κύπρος Αλκτωρ Φαρμακευτικ? Λτδ Τηλ: +357 22490305 | Sverige AstraZeneca AB Tel: +46 8 553 26 000 |
Latvija SIA AstraZeneca Latvija Tel: +371 67377 100 | United Kingdom (Northern Ireland) AstraZeneca UK Ltd Tel: +44 1582 836 836 |
Last update of the summary of product characteristics:
Other sources of information
The detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu .
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.